Current Net Margin
-507.77%
Taysha Gene Therapies, Inc. currently has a net profit margin of -507.77%.
Financial Fundamentals
TSHA • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.01 | -0.03 | -507.77% | — |
| 2025-09-30 | 0.00 | -0.03 | — | — |
| 2025-06-30 | 0.00 | -0.03 | -1353.58% | ▼41834 |
| 2025-03-31 | 0.00 | -0.02 | -935.23% | ▼620 |
| 2024-12-31 | 0.00 | -0.02 | -929.03% | ▲49849 |
| 2024-09-30 | 0.00 | -0.03 | -1427.52% | ▲45450 |
| 2024-06-30 | 0.00 | -0.02 | -1882.01% | ▼117662 |
| 2024-03-31 | 0.00 | -0.02 | -705.39% | ▼203006 |
| 2023-12-31 | 0.00 | 0.05 | 1324.67% | ▲379173 |
| 2023-09-30 | 0.00 | -0.12 | -2467.07% | ▼144001 |
| 2023-06-30 | 0.00 | -0.02 | -1027.06% | ▼65260 |
| 2023-03-31 | 0.00 | -0.02 | -374.46% | ▲185268 |
| 2022-12-31 | 0.00 | -0.06 | -2227.14% | — |
| 2022-09-30 | 0.00 | -0.03 | — | — |
| 2022-06-30 | 0.00 | -0.03 | — | — |
| 2022-03-31 | 0.00 | -0.05 | — | — |
| 2021-12-31 | 0.00 | -0.05 | — | — |
| 2021-09-30 | 0.00 | -0.05 | — | — |
| 2021-06-30 | 0.00 | -0.04 | — | — |
| 2021-03-31 | 0.00 | -0.03 | — | — |
| 2020-12-31 | 0.00 | -0.02 | — | — |
| 2020-09-30 | 0.00 | -0.02 | — | — |
| 2020-06-30 | 0.00 | -0.02 | — | — |
| 2020-03-31 | 0.00 | -0.01 | — | — |
| 2019-12-31 | 0.00 | -0.00 | — | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.